Related Experiment Video
Updated: Oct 11, 2025

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
Published on: October 27, 2023
Enhancing preclinical drug discovery with artificial intelligence
R S K Vijayan1, Jan Kihlberg2, Jason B Cross1
1Institute for Applied Cancer Science, MD Anderson Cancer Center, Houston, TX, USA.
Abstract:
Artificial intelligence (AI) is becoming an integral part of drug discovery. It has the potential to deliver across the drug discovery and development value chain, starting from target identification and reaching through clinical development. In this review, we provide an overview of current AI technologies and a glimpse of how AI is reimagining preclinical drug discovery by highlighting examples where AI has made a real impact. Considering the excitement and hyperbole surrounding AI in drug discovery, we aim to present a realistic view by discussing both opportunities and challenges in adopting AI in drug discovery.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Preclinical Development: Overview
Non-equilibrium in the Cell

